Meningitis Treatment and Prevention: Antibiotics, Antivirals, Vaccines
Neurological DisordersMeningitis
Explore This Topic

Meningitis Treatment and Prevention

Meningitis Treatment and Prevention
Everyday Health
By
Updated on March 18, 2025
by

Meningitis — inflammation of the membranes that surround the brain and spinal cord — can result from different causes, including viruses, bacteria, fungi, and parasites. Certain diseases like cancer and physical injury can also result in meningitis.

Meningitis treatment and prevention options differ depending on the reason for the illness.

Meningitis Treatment

Two main forms of meningitis are viral meningitis and bacteria meningitis. There are different treatments for each.

Viral Meningitis Treatment

In the United States, viruses are the most common cause of meningitis. These cases are generally mild, and patients typically recover in 7 to 10 days with rest, over-the-counter fever reducers or pain medications, and proper fluid intake.

Although there is no cure for viral meningitis, antiviral medications can help a person’s immune system fight the infection. These include:

  • Acyclovir (Zovirax) is an effective drug for two forms of viral meningitis: herpes simplex meningitis and varicella zoster (shingles) meningitis.
  • Antiretrovirals are for patients with meningitis caused by HIV; antiretroviral therapy stops the virus from replicating, or making copies of itself.

  • Ganciclovir (Cytovene) or foscarnet (Foscavir) may help with cytomegalovirus meningitis (CMV meningitis) in people with weakened immune systems.


Bacterial Meningitis Treatment

Bacterial meningitis is relatively rare, accounting for about 8 percent of cases. But it is considered a medical emergency because it sometimes leads to brain damage, seizures, paralysis, or stroke.

Intravenous antibiotics are the standard treatment, administered as quickly as possible, with the specific antibiotic depending on the type of bacteria.

 Healthcare providers may also prescribe corticosteroids to reduce inflammation for certain forms of meningitis, but especially bacterial.

Types of bacterial meningitis include:

Meningococcal Meningitis This is caused by the Neisseria meningitidis bacteria. Therapy for suspected disease may include a cephalosporin (a class of antibiotics), such as cefotaxime (Claforan) or ceftriaxone (Rocephin).

Depending on the exact microbial makeup of the bacteria, treatment could also involve penicillin or ampicillin.

Pneumococcal Meningitis Pneumococcus, also known as Streptococcus pneumoniae, is a type of bacteria that can result in one of the deadliest types of meningitis, with a fatality rate as high as 50 percent.

 Among those most at risk are babies and young children under age 2 and adults over 65.

Treatment would typically include one of the following:

  • penicillin or ampicillin (Amoxil, Moxilin, Sumox, Trimox)
  • fluoroquinolones (often called quinolones), such as levofloxacin (Levaquin) and moxifloxacin (Avelox)


Group B Streptococcal (GBS) Meningitis Caused by Streptococcus agalactiae bacteria, this is the most common cause of serious infections in newborns and can lead to meningitis, pneumonia, or sepsis. This is why pregnant women are screened for group B strep in their third trimesters.

Penicillin is the usual treatment.

H. Influenzae Meningitis Before widespread vaccination, Haemophilus influenzae type b (Hib) bacteria caused meningitis in 50 to 60 percent of infections.

Despite its name, this illness is not the same as the flu (influenza), which is caused by a virus.

The mortality rate for H. Influenzae Meningitis is 2 to 5 percent, and many who survive (15 to 30 percent) suffer some permanent neurologic damage, such as blindness, deafness, or intellectual disability.

Antibiotic options include:

  • ceftriaxone (Rocephin) or cefotaxime (Claforan) for more severe infections

Fungal or Parasitic Meningitis Treatment

If meningitis is fungal in nature, treatment typically depends on the fungus type. Medications include:

  • amphotericin B (Fungizone)
  • itraconazole (Sporanox)
  • fluconazole (Diflucan)
  • posaconazole (Noxafil)
  • isavuconazole (Cresemba)
  • voriconazole

Parasitic infections can also lead to meningitis. Treatment for parasitic eosinophilic meningitis focuses on a category of drugs called antinematodes, which includes:

  • mebendazole (Vermox)
  • albendazole (Albenza)
  • thiabendazole (Mintezol)


Meningitis Prevention

Vaccines can protect against a number of different forms of meningitis, while certain basic hygiene measures (like thorough hand-washing) can also be an effective form of prevention.

Vaccines for Viral Meningitis

No vaccines are available to protect against nonpolio enteroviruses, by far the most common cause of viral meningitis. But vaccines can prevent other meningitis-causing viruses.

MMR, Varicella, and MMRV Vaccines The MMR vaccine protects against three meningitis-causing viruses — measles, mumps, and rubella. The varicella vaccine protects against chickenpox, which can also cause meningitis. The MMRV vaccine is a combination of the two vaccines.

The CDC recommends MMRV vaccination for all children between 12 months and 12 years old, with the first of two shots given between ages 12 and 15 months, and the second given between ages 4 and 6 years.

Shingles Vaccine The CDC recommends that adults 50 and over get the shingles vaccines (Shingrix), as shingles infection can lead to meningitis; they need two doses, spaced two to six months apart.

Adults 19 and older with weakened immune systems should also get two doses of the shingles vaccine, if necessary getting the second dose one to two months after the first.

Vaccines for Bacterial Meningitis

Meningococcal Vaccines The Centers for Disease Control and Prevention (CDC) recommends vaccination for all preteens and teens.

Vaccines are formulated to protect against specific serotypes (groups of strains) of bacteria, identified by the letters A, B, C, W, and Y.

The CDC recommends that all children ages 11 and 12 receive one of the following:

  • Menveo (meningococcal groups A, C, Y, W oligosaccharide diphtheria)

  • MenQuadfi (meningococcal groups A, C, Y, W conjugate vaccine); note that MenQuadfi replaced Menactra in 2022.

The U.S. Food and Drug Administration (FDA) has approved vaccines for N. meningitis group B for people between ages 10 and 25:

  • Trumenba (meningococcal group B vaccine)

  • Bexsero (meningococcal group B vaccine)

  • Penmenvy (meningococcal groups A, B, C, W, and Y vaccine)

Pneumococcal (Pneumonia) Vaccine The CDC recommends pneumococcal (pneumonia) vaccination for children younger than 5 years, adults 50 years or older, and for children and adults at increased risk for pneumococcal disease, including people who have chronic underlying medical conditions that predispose them to serious illness, such as diabetes, heart disease, lung disease, being immune-compromised, or not having a spleen

The United States uses two types of pneumococcal vaccines:

  • Pneumococcal conjugate vaccines (PCVs)
  • Pneumococcal polysaccharide vaccine
    • PPSV23
The polysaccharide vaccine is used less often than it once was, and has basically been replaced by conjugate vaccines.

Hib Vaccine The CDC recommends H. influenzae type b (Hib or H Flu) vaccination for children younger than 5 years old.

Vaccines are for Hib only or in combinations with other vaccine:

  • ActHIB
  • Hiberix
  • PedvaxHIB
  • Pentacel
  • Vaxelis

Basic Hygiene Practices to Protect Against Meningitis

Because many meningitis-causing germs spread through respiratory fluids, you can protect yourself and prevent transmission to others by following some standard hygiene practices:

  • Wash your hands. Attentive hand-washing kills germs.
  • Don’t share drinks or food. You should also avoid sharing utensils, lip balms, and toothbrushes.
  • Maintain good health. Eat right, exercise, and get adequate rest to maintain a strong immune system.
  • Cover your mouth. To stop the spread of germs, cover your mouth and nose when sneezing or coughing.

The Takeaway

  • Treatment for meningitis (swelling of the membranes surrounding the brain and spinal cord) varies depending on what’s causing the condition.
  • Meningitis due to viruses tends to be mild and people generally recover on their own, but bacterial meningitis is considered a medical emergency and typically requires intravenous antibiotics.
  • Vaccines can help prevent meningitis, while certain simple hygiene measures (like washing your hands regularly) can prevent the spread of meningitis-causing germs.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. About Viral Meningitis. Centers for Disease Control and Prevention. January 9, 2024.
  2. Klein R. Viral Meningitis. Merck Manual. November 2024.
  3. Desmond R et al. Enteroviral Meningitis: Natural History and Outcome of Pleconaril Therapy. Antimicrobial Agents & Chemotherapy. July 2006.
  4. Antiretroviral Therapy. Cleveland Clinic. September 18, 2023.
  5. Kang GW et al. Ganciclovir and Foscarnet Therapy of Cytomegalovirus-Associated Meningoencephalitis in a Hemodialysis Patient With Liver Transplantation: Case Report. Transplantation Proceedings. May 2016.
  6. Berg S. What Doctors Wish Patients Knew About Bacterial Meningitis. American Medical Association. January 3, 2025.
  7. Bacterial Meningitis. Johns Hopkins Medicine.
  8. Clinical Guidance for Meningococcal Disease. Centers for Disease Control and Prevention. August 21, 2024.
  9. Wang B et al. Disease Burden of Meningitis Caused by Streptococcus pneumoniae Among Under-Fives in China: A Systematic Review and Meta-analysis. Infectious Diseases and Therapy. October 14, 2023.
  10. Pneumococcal Meningitis. Meningitis Research Foundation. December 16, 2024.
  11. Musher DM. Resistance of Streptococcus pneumoniae to the fluoroquinolones, doxycycline, and trimethoprim-sulfamethoxazole. UpToDate. October 16, 2024.
  12. Group B Streptococcus Infection in Babies. Cedars Sinai.
  13. Group B Streptococcus (GBS) in Adults: Commonly Asked Questions. Minnesota Department of Health. January 25, 2024.
  14. Haemophilus Influenzae Meningitis. Meningitis Research Foundation. December 27, 2024.
  15. Oliver S et al. Haemophilus influenzae. Centers for Disease Control and Prevention. May 21, 2024.
  16. Meningitis - H. influenzae. Mount Sinai.
  17. Haemophilus Influenzae Type B (Hib): Questions and Answers. Immunize.org.
  18. Anon JB et al. Antimicrobial Treatment Guidelines for Acute Bacterial Rhinosinusitis. Otolaryngology Head and Neck Surgery. January 2004.
  19. Khattak Z et al. Haemophilus Influenzae Infection. StatPearls. April 27, 2023.
  20. Thanaviratananich S et al. Corticosteroids for Parasitic Eosinophilic Meningitis. Cochrane Library. February 17, 2015.
  21. Measles, Mumps, and Rubella (MMR) Vaccination: What Everyone Should Know. Centers for Disease Control and Prevention. January 26, 2021.
  22. Shingles Vaccination. Centers for Disease Control and Prevention. July 19, 2024.
  23. Recommended Vaccines for Preteens and Teens. Centers for Disease Control and Prevention. October 24, 2024.
  24. Menveo. U.S. Food and Drug Administration. September 6, 2024.
  25. MenQuadfi. U.S. Food and Drug Administration. December 18, 2024.
  26. Trumenba. U.S. Food and Drug Administration. June 20, 2024.
  27. Bexsero. U.S. Food and Drug Administration. August 20, 2024.
  28. Penmenvy. GSK. February 17, 2025.
  29. Pneumococcal Vaccine Recommendations. Centers for Disease Control and Prevention. October 26, 2024.
  30. Hib Vaccine Recommendations . Centers for Disease Control and Prevention. June 26, 2024.
  31. Meningitis. Mayo Clinic. October 17, 2024.
Meet Our Experts
See Our Editorial PolicyMeet Our Health Expert Network
jane-yoon-scott-bio

Jane Yoon Scott, MD

Medical Reviewer

Jane Yoon Scott, MD, is an infectious disease physician and an assistant professor of medicine at Emory University in Atlanta. Dr. Scott enjoys connecting with her patients, empowering them to understand and take ownership of their health, and encouraging them to ask questions so that they can make informed and thoughtful decisions.

She graduated with the highest honors from the Georgia Institute of Technology, then received her MD from the Medical College of Georgia. She completed her internal medicine residency training and chief residency at Temple University Hospital, as well as a fellowship in infectious diseases at Emory University. She is board-certified in both internal medicine and infectious diseases.

When she is not seeing patients, Dr. Scott works with neighboring health departments to promote public health, especially to communities that have been historically underserved. She also teaches medical trainees and lectures medical students at the Emory University School of Medicine.

In her free time, Dr. Scott appreciates a good coffee shop, weekend hikes, playing guitar, strolling through cities, sampling restaurants, and traveling to new places.

See full bio

Don Rauf

Author

Don Rauf has been a freelance health writer for over 12 years and his writing has been featured in HealthDay, CBS News, WebMD, U.S. News & World Report, Mental Floss, United Press International (UPI), Health, and MedicineNet. He was previously a reporter for DailyRx.com where he covered stories related to cardiology, diabetes, lung cancer, prostate cancer, erectile dysfunction, menopause, and allergies. He has interviewed doctors and pharmaceutical representatives in the U.S. and abroad.

He is a prolific writer and has written more than 50 books, including Lost America: Vanished Civilizations, Abandoned Towns, and Roadside Attractions. Rauf lives in Seattle, Washington.

See full bio
See Our Editorial PolicyMeet Our Health Expert Network